DE60113300D1 - Piperazinylcarbonylchinoline und isochinoline - Google Patents

Piperazinylcarbonylchinoline und isochinoline

Info

Publication number
DE60113300D1
DE60113300D1 DE60113300T DE60113300T DE60113300D1 DE 60113300 D1 DE60113300 D1 DE 60113300D1 DE 60113300 T DE60113300 T DE 60113300T DE 60113300 T DE60113300 T DE 60113300T DE 60113300 D1 DE60113300 D1 DE 60113300D1
Authority
DE
Germany
Prior art keywords
piperazinylcarbonylchinoline
isochinoline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60113300T
Other languages
English (en)
Other versions
DE60113300T2 (de
Inventor
Henning Boettcher
Gerd Bartoszyk
Juergen Harting
Amsterdam Christoph Van
Christoph Seyfried
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Priority to DE60113300T priority Critical patent/DE60113300T2/de
Publication of DE60113300D1 publication Critical patent/DE60113300D1/de
Application granted granted Critical
Publication of DE60113300T2 publication Critical patent/DE60113300T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
DE60113300T 2001-01-17 2001-12-24 Piperazinylcarbonylchinoline und isochinoline Expired - Lifetime DE60113300T2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE60113300T DE60113300T2 (de) 2001-01-17 2001-12-24 Piperazinylcarbonylchinoline und isochinoline

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE10102053 2001-01-17
DE10102053A DE10102053A1 (de) 2001-01-17 2001-01-17 Piperazinylcarbonylchinoline und -isochinoline
PCT/EP2001/015311 WO2002057256A1 (en) 2001-01-17 2001-12-24 Piperazinylcarbonylquinolines and -isoquinolines
DE60113300T DE60113300T2 (de) 2001-01-17 2001-12-24 Piperazinylcarbonylchinoline und isochinoline

Publications (2)

Publication Number Publication Date
DE60113300D1 true DE60113300D1 (de) 2005-10-13
DE60113300T2 DE60113300T2 (de) 2006-06-29

Family

ID=7670921

Family Applications (2)

Application Number Title Priority Date Filing Date
DE10102053A Withdrawn DE10102053A1 (de) 2001-01-17 2001-01-17 Piperazinylcarbonylchinoline und -isochinoline
DE60113300T Expired - Lifetime DE60113300T2 (de) 2001-01-17 2001-12-24 Piperazinylcarbonylchinoline und isochinoline

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE10102053A Withdrawn DE10102053A1 (de) 2001-01-17 2001-01-17 Piperazinylcarbonylchinoline und -isochinoline

Country Status (23)

Country Link
US (1) US7329749B2 (de)
EP (1) EP1366039B1 (de)
JP (1) JP4417624B2 (de)
KR (1) KR100854481B1 (de)
CN (1) CN1249055C (de)
AR (1) AR035682A1 (de)
AT (1) ATE304010T1 (de)
BR (1) BR0116774A (de)
CA (1) CA2434773C (de)
CZ (1) CZ304144B6 (de)
DE (2) DE10102053A1 (de)
DK (1) DK1366039T3 (de)
ES (1) ES2248230T3 (de)
HK (1) HK1061849A1 (de)
HU (1) HU230250B1 (de)
MX (1) MXPA03006360A (de)
MY (1) MY127293A (de)
PL (1) PL212087B1 (de)
RU (1) RU2280034C2 (de)
SI (1) SI1366039T1 (de)
SK (1) SK287333B6 (de)
WO (1) WO2002057256A1 (de)
ZA (1) ZA200306331B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004525621A (ja) * 2001-01-18 2004-08-26 メルク　パテント　ゲゼルシャフト　ミット　ベシュレンクテル　ハフトング グルコセレブロシダーゼ活性を有する二機能性融合タンパク質
EP1496905B1 (de) * 2002-04-22 2008-08-13 Johns Hopkins University School of Medicine Modulatoren von hedgehog signalpfaden, zusammensetzungen und verwandte verwendungen
EP1517898A1 (de) * 2002-06-29 2005-03-30 Zentaris GmbH Aryl- und heteroarylcarbonylpiperazine und deren verwendung zur behandlung gutartiger und b sartiger tumorerkrankungen
US20090311242A1 (en) * 2004-07-29 2009-12-17 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine 2a receptor (5ht2a)
DE112010005848B4 (de) * 2010-09-06 2016-03-10 Guangzhou Institutes Of Biomedicine And Health, Chinese Academy Of Sciences Amidverbindungen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4970714A (en) * 1989-01-05 1990-11-13 International Business Machines Corp. Adaptive data link protocol
ATE280759T1 (de) * 1997-07-07 2004-11-15 Kowa Co Diaminderivate und pharmazeutische zusammensetzungen die diese enthalten
CN1261098C (zh) * 1998-08-28 2006-06-28 西奥斯股份有限公司 p38－α激酶的抑制剂
DE19934433A1 (de) * 1999-07-22 2001-01-25 Merck Patent Gmbh N-(Indolcarbonyl-)piperazinderivate

Also Published As

Publication number Publication date
JP2004517145A (ja) 2004-06-10
HK1061849A1 (en) 2004-10-08
US7329749B2 (en) 2008-02-12
KR20030068579A (ko) 2003-08-21
CA2434773C (en) 2011-10-04
EP1366039B1 (de) 2005-09-07
RU2003124077A (ru) 2005-01-10
DK1366039T3 (da) 2006-01-02
CN1249055C (zh) 2006-04-05
JP4417624B2 (ja) 2010-02-17
DE10102053A1 (de) 2002-07-18
HUP0401038A2 (hu) 2004-08-30
WO2002057256A9 (en) 2005-12-08
DE60113300T2 (de) 2006-06-29
SI1366039T1 (sl) 2006-02-28
KR100854481B1 (ko) 2008-08-26
BR0116774A (pt) 2004-01-06
CA2434773A1 (en) 2002-07-25
ES2248230T3 (es) 2006-03-16
US20040077657A1 (en) 2004-04-22
SK8652003A3 (en) 2003-11-04
RU2280034C2 (ru) 2006-07-20
MXPA03006360A (es) 2003-10-06
SK287333B6 (sk) 2010-07-07
MY127293A (en) 2006-11-30
WO2002057256A1 (en) 2002-07-25
HUP0401038A3 (en) 2011-08-29
CZ20031861A3 (cs) 2003-09-17
ATE304010T1 (de) 2005-09-15
AR035682A1 (es) 2004-06-23
PL361741A1 (en) 2004-10-04
EP1366039A1 (de) 2003-12-03
CZ304144B6 (cs) 2013-11-20
PL212087B1 (pl) 2012-08-31
ZA200306331B (en) 2005-01-26
CN1486308A (zh) 2004-03-31
HU230250B1 (hu) 2015-11-30

Similar Documents

Publication Publication Date Title
DE50112013D1 (de) Deodorantien und antiperspirantien
DE60212600D1 (de) Audiocodierung und decodierung
DE60234554D1 (de) Keramisches Filter und Katalysator-beladenes keramisches Filter
DE50115561D1 (de) Spektralphotometer und Verwendung desselben
DE60221512D1 (de) Wabenstrukturkörper und anordnung dafür
DK1417175T3 (da) Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf
DE60215046D1 (de) Vernebler und anwendungsverfahren
ATE450663T1 (de) Verschleissteil und -anordnung
DE10295851T1 (de) Dachfensterbaueinheit und Einzelteile
PT1411764E (pt) Cerca
DE60233444D1 (de) Teileanbringvorrichtung und teileanbringverfahren
DE10294402D2 (de) Estrogen-Gestagen Kombinationspräparat und Anwendung
NO20035121D0 (no) Ny anvendelse
DE60220486D1 (de) Zurückschaltungseinrichtung und Zurückschaltungsverfahren
DE60208982D1 (de) Fussbad
DE60229938D1 (de) ENTWICKLUNGSEINRICHTUNG UND BILDformungsgerät
DE60216815D1 (de) Perfluoradamantylacrylatverbindung und zwischenprodukt dafür
DE60208700D1 (de) Schälgerät und zugehörige verfahren
DE60209419D1 (de) Kollimator und Spektrophotometer
DE60223540D1 (de) Mundschutz und mundschutzfolie
DE60203475D1 (de) Drosselklappe und Drossel
DE50201691D1 (de) Thermischer applikator und applikatorsystem
DE60113300D1 (de) Piperazinylcarbonylchinoline und isochinoline
DK1392670T3 (da) Substituerede C-furan-2-yl-methylamin- og C-thiophen-2-yl-methylamin-derivater
DE60232751D1 (de) Steckverbinder und Stecker

Legal Events

Date Code Title Description
8364 No opposition during term of opposition